Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Flavio Albarracin"'
Autor:
Andrea Bacigalupo, Alida Dominietto, Sarah Pozzi, Maurizio Miglino, Flavio Albarracin, Giovanna Piaggio, Francesca Bertolotti
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 30, Pp 42-44 (2008)
Minimal residual disease (MRD) was monitored in 80 patients with acute lymphoid (ALL, n=44) or myeloid (AML, n=36) leukemia, undergoing allogeneic haemopoietic stem cell transplantations. MRD markers were IgH-VDJ and TCR gene re-arrangement for ALL,
Externí odkaz:
https://doaj.org/article/a2d82cb38ef846afaf683cc0bdcde3df
Autor:
Flavio Albarracin, Jorge Solimano
Publikováno v:
Revista Hematología. 26:53-54
“No sé lo que quiero, pero lo quiero ya”, reza la letra de Luca Prodan, aquel genial artista nacido en Roma y educado en el colegio escocés de altísima sociedad Gordonstoun School (por cierto, asistía el Príncipe Carlos de Inglaterra en ese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::650a4e5dfd2fbe7941338564f33fa2b1
https://doi.org/10.48057/hematologa.v26i2.474
https://doi.org/10.48057/hematologa.v26i2.474
Autor:
Flavio Albarracin, Rafael Fonseca
Plasma cell leukemia (PCL) is a rare, yet aggressive plasma cell (PC) neoplasm, variant of multiple myeloma (MM), characterized by high levels of PCs circulating in the peripheral blood. PCL can either originate de novo (primary PCL) or as a secondar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d65d97f970de68cea8a3c3ce1a5b2ad2
https://europepmc.org/articles/PMC3907188/
https://europepmc.org/articles/PMC3907188/
Autor:
Flavio Albarracin, Maurizio Miglino, Giovanna Piaggio, Sarah Pozzi, Francesca Bertolotti, Andrea Bacigalupo, Alida Dominietto
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia v.30 suppl.2 2008
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Minimal residual disease (MRD) was monitored in 80 patients with acute lymphoid (ALL, n=44) or myeloid (AML, n=36) leukemia, undergoing allogeneic haemopoietic stem cell transplantations. MRD markers were IgH-VDJ and TCR gene re-arrangement for ALL,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70bd701252f5d8bc7c1dd49da3d06768
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800011
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800011
Autor:
Simona Zupo, Raffaella Grasso, Alida Dominietto, Andrea Bacigalupo, Anna Maria Raiola, Maurizio Miglino, Francesca Bertolotti, Giovanna Piaggio, Francesco Frassoni, Flavio Albarracin, Marco Gobbi, Sarah Pozzi
To the editor: Hematologic relapse after an allogeneic hemopoietic stem cell transplantation (HSCT) in patients with acute leukemia is associated with a poor outcome, despite further cell therapy in the form of donor lymphocyte infusions (DLIs).[1][1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad7b2f102d92ed2e52d1205d8087b4f9
http://hdl.handle.net/11567/225735
http://hdl.handle.net/11567/225735
Publikováno v:
Maskana, Vol 6, Iss 1, Pp 149-167 (2015)
En este documento se analiza la factibilidad y eficiencia de la deflectometría de impacto para evaluar la capacidad portante de la estructura de un pavimento flexible en vías locales de la red austral E40. Mediante el equipo no destructivo conocido
Externí odkaz:
https://doaj.org/article/28847d6ac3b24e3f9eb30e56a40d3b34